Provided by Tiger Trade Technology Pte. Ltd.

Usana Health Sciences

17.19
+0.18001.06%
Post-market: 17.190.00000.00%16:10 EDT
Volume:104.48K
Turnover:1.79M
Market Cap:317.27M
PE:29.67
High:17.40
Open:17.20
Low:16.98
Close:17.01
52wk High:38.32
52wk Low:16.72
Shares:18.46M
Float Shares:9.44M
Volume Ratio:0.71
T/O Rate:1.11%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.5793
EPS(LYR):0.5793
ROE:1.96%
ROA:4.26%
PB:0.60
PE(LYR):29.67

Loading ...

Aug 11, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 30, 2021

Major Issues Report

8-K - Current report
Jul 27, 2021

Major Issues Report

8-K - Current report
Jun 21, 2021

Employee Stock Ownership

11-K - Annual report of employee stock purchase, savings and similar plans
May 13, 2021

Major Issues Report

8-K - Current report
May 11, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 27, 2021

Major Issues Report

8-K - Current report
Mar 11, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Mar 02, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 16, 2021

Major Issues Report

8-K - Current report
Feb 11, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2021

Major Issues Report

8-K - Current report
Feb 01, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Nov 05, 2020

[Rev.]Quaterly Report

10-Q/A [Amend] - Quarterly report [Sections 13 or 15(d)]
Nov 03, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 20, 2020

Major Issues Report

8-K - Current report
Sep 08, 2020

Major Issues Report

8-K - Current report
Aug 27, 2020

Major Issues Report

8-K - Current report
Aug 24, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership